NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in NEO / NeoGenomics, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of NeoGenomics, Inc. (US:NEO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 2,542,339 shares of NeoGenomics, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 0 -100.00 0
2025-11-13 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 2,542,339 -2,265,012 -47.12 19,627 -44.15 0.0229
2025-08-14 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 4,807,351 130,729 2.80 35,142 -20.82 0.0431
2025-08-14 2025-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 4,676,622 864,393 22.67 44,381 -29.36 0.0551
2025-05-15 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 4,676,622 864,393 44,381 0.0363
2025-02-14 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 3,812,229 -12,389 -0.32 62,826 11.37 0.0762
2024-11-14 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 3,824,618 561,232 17.20 56,413 24.63 0.0609
2024-08-09 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 3,263,386 -760,123 -18.89 45,263 -28.44 0.0519
2024-05-14 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 4,023,509 -57,670 -1.41 63,250 -4.21 0.0717
2024-02-14 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 4,081,179 1,062,226 35.19 66,033 77.83 0.0763
2023-11-14 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 3,018,953 748,900 32.99 37,133 1.79 0.0466
2023-10-27 2023-06-30 13F/A-2 NEOGENOMICS COM NEW 64049M209 2,270,053 245,699 12.14 36,480 3.51 0.0417
2023-10-12 2023-06-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 2,270,053 245,699 36,480 0.0367
2023-08-14 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 2,270,053 245,699 36,480 0.0370
2023-06-01 2023-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 2,024,354 55,780 2.83 35,244 93.75 0.0419
2023-05-15 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 2,024,354 55,780 35,244 0.0324
2023-02-21 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 1,968,574 50,298 2.62 18,190 10.08 0.0215
2022-11-14 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 1,918,276 33,262 1.76 16,524 7.56 0.0203
2022-08-17 2022-06-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 1,885,014 -105,593 -5.30 15,363 -36.48 0.0172
2022-08-15 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 1,885,014 -105,593 15,363 0.0055
2022-05-16 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 1,990,607 606,003 43.77 24,186 -48.80 0.0184
2022-02-11 2021-12-31 13F Neogenomics COM NEW 64049M209 1,384,604 -657,852 -32.21 47,242 -52.05 0.0394
2021-11-12 2021-09-30 13F NEOGENOMICS COM NEW 64049M209 2,042,456 1,170,745 134.30 98,528 150.23 0.0840
2021-08-13 2021-06-30 13F NEOGENOMICS COM NEW 64049M209 871,711 867,877 22,636.33 39,375 21,183.78 0.0323
2021-05-14 2021-03-31 13F NEOGENOMICS COM NEW 64049M209 3,834 -385 -9.13 185 -18.50 0.0003
2021-02-16 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 4,219 0 0.00 227 45.51 0.0003
2020-11-13 2020-09-30 13F NEOGENOMICS COM NEW 64049M209 4,219 0 0.00 156 19.08 0.0003
2020-08-11 2020-06-30 13F NEOGENOMICS COM NEW 64049M209 4,219 1,046 32.97 131 48.86 0.0002
2020-05-15 2020-03-31 13F NEOGENOMICS COM NEW 64049M209 3,173 3,173 88 0.0002
2019-05-15 2019-03-31 13F NEOGENOMICS COM NEW 64049M209 0 -863 -100.00 0 -100.00
2019-02-15 2018-12-31 13F NEOGENOMICS COM NEW 64049M209 863 863 11 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.